The Net Margin of Myovant Sciences Ltd (MYOV) is
-89.18%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2022-03-31 |
-89.18%
|
| 2021-03-31 |
-430.09%
|
| Ticker |
Name |
Value |
|
OCGN
|
Ocugen, Inc.
|
-1537.41%
|
|
FPRX
|
Five Prime Therapeutics Inc
|
-639.91%
|
|
RCUS
|
Arcus Biosciences, Inc.
|
-142.91%
|
|
CNTA
|
Centessa Pharmaceuticals Limited
|
-1316.88%
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
-346.20%
|
|
DMTK
|
DermTech Inc
|
-659.57%
|
|
GBIO
|
Generation Bio Co
|
-661.91%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
-314.90%
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
-819.59%
|
|
ABC.L
|
Abcam PLC
|
3.72%
|
|
CYTK
|
Cytokinetics, Incorporated
|
-891.60%
|
|
BCAB
|
Bioatla Inc
|
-2980.35%
|
|
BCYC
|
Bicycle Therapeutics PLC
|
-301.66%
|
|
CCCC
|
C4 Therapeutics, Inc.
|
-292.08%
|
|
GNS.L
|
Genus PLC
|
43.35%
|
|
PAND
|
Pandion Therapeutics Inc
|
-2262.36%
|
|
VBIV
|
VBI Vaccines Inc
|
-1069.29%
|
|
ALVR
|
Allovir Inc
|
-14023.53%
|
|
ALEC
|
Alector, Inc.
|
-679.16%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
-130005.97%
|
|
KRON
|
Kronos Bio LLC
|
-874.08%
|
|
KRYS
|
Krystal Biotech, Inc.
|
52.64%
|
|
KURA
|
Kura Oncology, Inc.
|
-412.95%
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
-794.04%
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
-39.78%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
721.93%
|
|
IMCR
|
Immunocore Holdings PLC
|
-8.88%
|
|
ZYME
|
Zymeworks Inc.
|
-76.56%
|
|
ADCT
|
Adc Therapeutics Ltd
|
-175.31%
|
|
SLN.L
|
Silence Therapeutics PLC
|
-594.03%
|
|
OXB.L
|
Oxford Biomedica PLC
|
-17.85%
|